Regarding muscle function, administering ghrelin, GHSR agonists, or an agent that boosts plasma ghrelin ameliorates reduced muscle contraction force and skeletal muscle wasting in rodent cachexia and muscle atrophy models and improves muscle strength in patients with cancer cachexia (8–13). The gene discussed is GHRL; the disease is Cachexia.